Connecting innovators and stakeholders to create business value

3 downloads 28 Views 7MB Size Report
Beauty [email protected] ... Recruiting new Amway Business Owners. • Motivating ... Idea to Market (ITM) via Stage-Gate commercialization model.
Connecting innovators and takeholders to create usiness value

. Deepa Shenoy, PhD novation Strategy pen Innovation – New Technology Health & auty [email protected]

• Leader in the CPG industry • Founded in 1959 • 80 countries and territories • 450 products focused on health, wellness & beauty • 15,000 employees worldwide • 5,000,000 independent distributors

Benefits to Amway’s IBO • Selling / Sharing the product • Recruiting new Amway Business Owners • Motivating higher renewal/retention rates • Generating personal volume

Where We Do Business

he First 25 Years

The Second 25 Years

bal R&D Facilities

Buena Park, California

Lakeview, California

trical Engineering hanical Engineering ess Engineering mical Engineering

Guanzhou, China

Ada, Michigan Shanghai, China

Areas of Functional Expertise Agricultural Research Product Development Package Engineering Industrial Engineering

Consumer Product Research Analytical Sciences Technical Regulatory Affairs Quality Engineering

mway Product Categories:

rition – Beauty – Home care – Personal care –Durables – Cookw

Amway India Founded in 1995 Headquartered in Gurgaon, HR 2 manufacturing sites and 7 contract manufacturing partners 130 products in all 5 product categories 13 years of commercial operation 135 offices, 55 city warehouses, 4 regional mother warehouses with the support of independent logistics partners over 5500 locations.

Our MISSION is to Discover, Develop & Deliver Products & Solutions for Independent Business Owners in Global Markets

Open Innovation (OI) New Technologies for Strategic Growth Opportunity Areas (SGOAs)

Connecting with people, companies and organizations internally and externally to develop creative solutions to meet business and consumer needs.

Who can be an Amway OI collaborator Internal Scientists and Technology Scouts Suppliers (ingredients, devices) Industry and academic researchers Branded product companies Entrepreneurs Investment groups

Potential Partners

Open Innovation Champion

Amway

Internal Stakeholders • Product Development • Technical Regulatory Affairs • Project Management • Procurement • Marketing and Communication • Sales and Distribution • Legal, Finance and Forecasting • Affiliates/ Sales/ IBOs/ Consumers • Manufacturing • Corporate Enterprise and Business Innovations Group

Championing the technology

Open Innovation Process Overview

time in discovery, due nce and strategy of ologies

of time in development of ologies

Technologies submitte to the OI team

Qualify for a feasibilit assessment

Considered breakthro “ideas”

Approved for funding and development

Enter the stage-gate development process

to Market (ITM) via Stage-Gate commercialization model BUSINESS PLAN

BUSINESS CASE

PROJECT PROPOSAL

PROJECT BRIEF

1st MARKET LAUNCH

Ideas

Ideas

CONCEPT DEVELOPMENT BUSINESS CASE DEVELOPMENT PROJECT BRIEF DEVELOPMENT

CONCEPT DEVELOPMENT

Ideas

PRODUCT DEVELOPMENT

VALUE CHAIN & SST’s

BUSINESS CASE DEVELOPMENT Ideas

CONCEPT DEVELOPMENT

Decisions

Ideas

Filters

OPEN INNOVATION CHAMPION EXPLORATION PRODUCT DEVELOPMENT

Pre-ITM Discovery Process is focused on next generation product solutions in market

echnology

Consumer Consumer Opportunity

Technology Solution Business Value

Business Value

Next Genera Product Port

Preliminary Technology Assessment PTA)

A measure to assess the maturity of evolving technologies prior to incorporating that technology into a product.

Technology Readiness Level (TRL – 1,2,3)

•Benefit or Solution

•Reason to believe or Mechanism of Action

•Nature of Evidence or Clinical Efficacy and Functionality

•Intellectual Property and Exclusivity

•Safety and Regulatory

•Market Assessment

•Commercial Viability

xample: Next Generation Technology for Curcumin

RL1 < TRL2 < TRL3 < pre-ITM< ITM to Market • What are the proposed claims and do they fit in the current technology plan? What is the competitive landscape? What is the cost to market? • Is there human data? Does the dosage used in the human study align with the animal research? Was the study blinded or was a control group used?How many participants were in the trial? Does the study population match your target population? How long was the trial?Were the results plausible? Where was the study conducted? Is the data published in a peerreviewed journal? • Is there a known mechanism of action for how the ingredient may impact your desired target? Can that mechanism be linked to a health benefit? Do the outcomes make sense? Were there any adverse reactions and do they link to the ingredients MOA? Do other ingredients with similar phytochemicals display similar benefits? How well dose the research support the proposed claims?

ternal Assessment For Technology Readiness

Reliability Testing

Shanghai R&D

Bioassay

Ag Research

Clinical Testing

Rapid Prototyping

Quality

Skin Imaging Lab

Sensory Testing

17 High-Impact Products in 55 markets since OI team was formed in 2005

Possibilities and Outcomes for OI partners • Access to new markets and/or channels • Long term supplier relation with Amway • Joint IP, Licensing Agreement, Option Agreement, Research Agreement, and/or Purchase Agreement • Access to Amway’s supplier network • Other Amway business opportunities

THANK YOU

Deepa Shenoy, PhD ovation Strategy en Innovation – New Technology [email protected]